An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Hum Mol Genet. 2016;25(17):3863-3876.

Wyszynski A, Hong CC, Lam K, Michailidou K et al.

Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol. 2016;34(24):2888-98.

Wentzensen N, Poole EM, Trabert B et al.

Age-and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. J Clin Oncol. 2016;34(23):2750-60.

Schmidt MK, Hogervorst F, van Hien R et al.

RAD51B in Familial Breast Cancer. PLoS One. 20165;11(5):e0153788.

Pelttari LM, Khan S, Vuorela M et al.

Five endometrial cancer risk loci identified through genome-wide association analysis. Nat Genet. 2016;48(6):667-74.

Cheng TH, Thompson DJ, O'Mara TA et al.

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nat Commun. 2016;7:11375.

Couch FJ, Kuchenbaecker KB, Michailidou K et al.

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. Int J Cancer. 2016;139(6):1303-17.

Shi J, Zhang Y, Zheng W, Michailidou K et al.

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes Control. 2016;27(5):679-93.

Zhao Z, Wen W, Michailidou K et al.

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat Genet. 2016;48(4):374-86.

Dunning AM, Michailidou K, Kuchenbaecker KB et al.

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. J Med Genet. 2016;53(5):298-309.

Easton DF, Lesueur F, Decker B et al.


Subscribe to Publications